Kimberly-Clark buys Tylenol maker Kenvue in a cash and stock deal for $48.7 billion

Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer health goods company.Shareholders of Kimberly-Clark will own about 54% of the combined company. Kenvue shareholders will own about 46%.The combined company will have a large stable of household brands under one roof, putting Kenvue’s Listerine mouthwash and Band-Aid side-by-side with Kimberly-Clark’s Cottonelle toilet paper, Huggies, and Kleenex tissues. It will also generate about$ ...